2018 Lectures

By http://www.midatlanticretina.com/author
April 19, 2018

COLE EYE INSTITUTE CLEVELAND CLINIC RETINA SUMMIT, Honolulu, Hawaii--April 27th--Dr. Allen Ho presented two lectures on "Surgical Drug Delivery" and "Gene Therapy for AMD and other Retinal Diseases".

FIFTH ANNUAL INNOVATIVE SUMMIT FOR RETINAL CELL AND GENE THERAPY, Honolulu, Hawaii--April 27th--Dr. Allen Ho was also invited to speak at the Fifth Annual Innovative Summit for Retinal Cell and Gene Therapy to present on "RGX-314 Gene Therapy Subretinal Delivery for the Treatment of Neovascular Age-Related Macular Degeneration (nAMD).

VIT-BUCKLE SOCIETY MEETING-- March 22nd-24th -Dr Michael Klufas and Dr Carl Regillo  moderated sessions at the Vitrectomy Buckle Society meeting last week as well.

TELLURIDE  RETINA FESTIVAL, Telluride, Colorado--March 15th-18th--Dr Carl Regillo was a moderator and Dr Allen Ho & Dr Michael Klufas were invited speakers at the Telluride Retina Film Festival in Telluride, Colorado.  They presented on "Subretinal Delivery Techniques".

SNOWMASS RETINA AND EYE MEETING, SNOWMASS, COLORADO--March 12th-March 16th-- Carl Regillo was an invited speaker and gave the Donald Gass lecture on “Optimizing Long-term Neovacular AMD treatment Outcomes” along with a lecture entitled “Emerging Neovascular AMD treatments”

ASPEN RETINA DETACHMENT SOCIETY MEETING, ASPEN, COLORADO--March 3rd-7th--Dr Carl Regillo was an invited speak at the 46th Annual Aspen Retina Detachment Society Meeting in Aspen, CO and spoke on "Optimizing AMD therapy" and the “Role of Scleral Buckling in Retinal Detachment Repair” (photo below)

MACULA SOCIETY MEETING, LOS ANGELES CA--February 21st-24th -- Dr Allen Ho presented "A Retrospective Analysis of Real-World Disease Detection and Visual Acuity Outcomes in Patients with Dry AMD converting to Wet AMD Using the AAO IRIS Registry Database" and was a Co-moderator on "Neovascular AMD II".

HAWAIIAN EYE RETINA MEETING, Kihei, Hawaii--January 13th-20th--Dr Allen Ho presented "Gene Therapy for Neovascular Age-Related Macular Degeneration" and "New Oral Anticoagulants and The Management of Hemorrhagic Age-Related Macular Degeneration"




Comments are closed.